BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2026.
World J Clin Cases. Jan 16, 2026; 14(2): 117140
Published online Jan 16, 2026. doi: 10.12998/wjcc.v14.i2.117140
Table 2 Proposed mechanisms of azole-induced male hypogonadism
Drugs
Mechanism
Clinical manifestation
Ketoconazole[46,54]Inhibition of 17-alpha hydroxylase and 17,20 lyaseDecreased libido
Increased estrogen: Testosterone ratioGynecomastia
Binding to androgen receptorOligospermia; azoospermia
Posaconazole[52]Inhibition of 11-β hydroxylaseGynecomastia
Compensatory increase in steroidogenesis
Peripheral aromatization of testosterone to estrogen
Inhibition of CYP3A4 and CYP3A7 slows down the hepatic metabolism of estrogen
Itraconazole[49]UnknownGynecomastia
Loss of libido


Write to the Help Desk